Evidence map›Paper›PMID 34378306›Full record

ReviewJournal of cellular and molecular medicine2021

Innate lymphoid cells are double-edged swords under the mucosal barrier.

Zhen Duan, Mandie Liu, Lin Yuan, Xizi Du, Mengping Wu, Yu Yang, Leyuan Wang, Kai Zhou, Ming Yang, Yizhou Zou and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of cellular and molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Innate lymphoid cells are double-edged swords under the mucosal barrier.Journal of cellular and molecular medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Zhen DuanDepartment of Physiology, School of Basic Medicine Science, Central South University, Changsha, China.
Mandie LiuDepartment of Physiology, School of Basic Medicine Science, Central South University, Changsha, China.
Lin YuanDepartment of Physiology, School of Basic Medicine Science, Central South University, Changsha, China.
Xizi DuDepartment of Physiology, School of Basic Medicine Science, Central South University, Changsha, China.
Mengping WuDepartment of Physiology, School of Basic Medicine Science, Central South University, Changsha, China.
Yu YangDepartment of Physiology, School of Basic Medicine Science, Central South University, Changsha, China.
Leyuan WangDepartment of Physiology, School of Basic Medicine Science, Central South University, Changsha, China.
Kai ZhouDepartment of Physiology, School of Basic Medicine Science, Central South University, Changsha, China.
Ming YangCentre for Asthma and Respiratory Disease, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle and Hunter Medical Research Institute, Callaghan, NSW, Australia.
Yizhou ZouDepartment of Immunology, School of Basic Medicine Science, Central South University, Changsha, China.
Yang XiangDepartment of Physiology, School of Basic Medicine Science, Central South University, Changsha, China.
Xiangping QuDepartment of Physiology, School of Basic Medicine Science, Central South University, Changsha, China.
Huijun LiuDepartment of Physiology, School of Basic Medicine Science, Central South University, Changsha, China.
Xiaoqun QinDepartment of Physiology, School of Basic Medicine Science, Central South University, Changsha, China.
Chi LiuDepartment of Physiology, School of Basic Medicine Science, Central South University, Changsha, China.ORCID 0000-0003-2872-9576
Central South University · CNHunter Medical Research Institute · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the direct contacting site for pathogens and allergens, the mucosal barrier plays a vital role in the lungs and intestines. Innate lymphoid cells (ILCs) are particularly resident in the mucosal barrier and participate in several pathophysiological processes, such as maintaining or disrupting barrier integrity, preventing various pathogenic invasions. In the pulmonary mucosae, ILCs sometimes aggravate inflammation and mucus hypersecretion but restore airway epithelial integrity and maintain lung tissue homeostasis at other times. In the intestinal mucosae, ILCs can increase epithelial permeability, leading to severe intestinal inflammation on the one hand, and assist mucosal barrier in resisting bacterial invasion on the other hand. In this review, we will illustrate the positive and negative roles of ILCs in mucosal barrier immunity.

Indexed as

AnimalsHumansImmunity, InnateIntestinal MucosaLymphocytesRespiratory Mucosaepithelial cellsinnate lymphoid cells (ILCs)mucosal barriermucosal diseases

Identifiers

PMID34378306
PMCPMC8435454
OpenAlexW3190649362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.